OrganoClick AB (ORGC) Fair Value & Analysis

Basic Materials · SE · Market cap 81.7M SEK

Below-average quality, and screening another 86% overvalued on our models.

What matters now

• The price sits above even our optimistic bull case (kr 0.0800). The favourable scenario is already priced in.
• Weak quality (24/100) and above fair value at the same time, the margin of safety is missing on both counts.
• The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
• A fairly wide model range (kr 0.0400 to kr 0.0800) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 15, 2026.

How to read this chart

60‑month range kr 0.3600 – kr 14.00 · fair‑value band kr 0.0400 – kr 0.0800 · the kr 0.4170 price screens above the kr 0.0600 fair value. Dashed = 300-day average. As of Jul 15, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

OrganoClick AB (ORGC) currently trades at kr 0.4170, while our model-based Fair Value estimate is kr 0.0600, implying the stock looks roughly 85.6% overvalued today. The Quality Score stands at 24/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, OrganoClick AB generated revenue of 98.2M SEK at a net margin of -35.2%. Revenue declined 22.7% year over year. Net debt stands at 75.1M SEK. Fundamentals as of Jul 15, 2026

Our scenario range runs from kr 0.0400 (bear case) to kr 0.0800 (bull case); at kr 0.4170, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -86%, ORGC screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Key figures & financial health

Quality Score breakdown

About the company

OrganoClick AB (publ), a green chemical company, develops and markets biobased and biodegradable chemical products and material technologies for the treatment of nonwoven, technical textile, and wood in Sweden, Other Nordics, the Rest of Europe, Asia, North America, and Oceania.

Full company description

OrganoClick AB (publ), a green chemical company, develops and markets biobased and biodegradable chemical products and material technologies for the treatment of nonwoven, technical textile, and wood in Sweden, Other Nordics, the Rest of Europe, Asia, North America, and Oceania. The company offers OrganoTex, a biodegradable and durable water repellent (DWR) technology for textile and shoe impregnation, and detergents; OrganoWood, a timber product and a wood preservative technology that provides wood with protection against decay and termites; and OrganoComp, a bio composite that is used for 3D forming. It also provides BIOkleen maintenance and cleaning products, as well as paint removal products; OC-BioBinder, a biobased and biodegradable binder used in nonwoven and technical textiles; and OC-AquaSil Tex, a biodegradable hydrophobing product used in nonwovens, specialty papers, and technical textiles. The company sells its products through a network of retailers. It serves the nonwoven, paper, textile, wood treatment, and construction industries, as well as consumers and homeowners. OrganoClick AB (publ) was incorporated in 2006 and is headquartered in Täby, Sweden.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

OrganoClick AB reported revenue of kr 106M in FY2025 versus kr 110M in FY2021, a compound −0.9%/yr. Reported net income was −kr 36.4M in FY2025.

ORGC screens 86% overvalued. Compare with Linde plc →

Peer Group

Specialty Chemicals · 673 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).

Explore undervalued stocks

More undervalued Basic Materials stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.